eCOO® Technology is Leader Biomedical’s unique proprietary platform that encompasses several technology handles for cleaning, sterilising, and impregnating biological and synthetic grafts. This technology provides a mild and efficient platform to clean and sterilise tissue with limited use of chemicals. Research has shown that the use of scCO2 minimally affects the structural integrity of tissue grafts when compared to conventional processing techniques. scCO2 treatment also removes medullary tissues responsible for adverse immune response.
For more information about the eCOO® Technology, please visit the Leader Biomedical website.